14 March 2014 WG-II-2014 Revised draft agenda Biocides Working Group Meeting II - 2014 24-28 March 2014 ECHA Conference Centre (Annankatu 18, Helsinki) Coffee break 11:00-11:30 Lunch break 13:00-14:00 Coffee break 15:30-16:00 Monday 24 March Tuesday 25 March Wednesday 26 March Thursday 27 March Friday 28 March 09:30-13:00 14:00-18:00 09:00-13:00 14:00-18:00 09:00-13:00 13:00-19:00 09:00-13:00 14:00-18:00 09:00-13:00 14:00-16:00 Human Health WG Analytical methods and physico-chemical properties WG Efficacy WG + Efficacy guidance Workshop WebEx only; no physical meeting Breaks to be agreed during meeting Environment WG 1
Human Health Working Group Chair: Antero Airaksinen Item 1 Welcome and apologies Item 2 Agreement of the agenda Item 3 Declarations of potential conflicts of interest in relation to the agenda Item 4 Administrative issues 4.1 Housekeeping issues Item 5 Discussion of active substances 5.1 CO 2 (eca NL) PT 15 (new active substance) Meeting document: WGII2014_TOX_5-1 5.2 OIT (eca UK) PT 6, 13 Early WG discussion during eca evaluation Meeting document: WGII2014_TOX_5-2 5.3 Copper pyrithione (eca SE) PT 21 Meeting document: WGII2014_TOX_5-3 Previous discussion(s): TM III 2011 and TM I 2012; CA meeting in September 2013 2
5.4 Dinotefuran (eca UK) PT 18 (new active substance) Meeting document: WGII2014_TOX_5-4 5.5 C(M)IT/MIT (eca FR) PT 2, 4, 6, 11, 12, 13 Meeting document: WGII2014_TOX_5-5 Item 6 Technical and guidance related issues 6.1 Recommendation of the Ad hoc WG on Human Exposure: Hand disinfection (PT 01) - Harmonisation of exposure determinants for professional users Meeting document: WGII2014_TOX_6-1 6.2 Recommendation of the Ad hoc WG on Human Exposure: Application duration to be used in wiping and mopping (PT2) Meeting document: WGII2014_TOX_6-2 6.3 Guidance development SECR to inform Item 7 AOB 7.1 R4BP 3 SECR to inform on versions 3.1 and 3.2 7.2 Lessons learned SECR to reflect on the experience gained 3
Analytical methods and physico-chemical properties Working Group Chair: Bernhard Krebs Item 1 Welcome and apologies Item 2 Agreement of the agenda Item 3 Declarations of potential conflicts of interest in relation to the agenda Item 4 Administrative issues 4.1 Housekeeping issues Item 5 Establishment of a reference specification 5.1 Reference source for biocidal active substances under the Biocidal Products Regulation (BPR) (EU) No 528/2012 Meeting document: WGII2014_APCP_5-1 5.2 Requirements for technical equivalence/chemical similarity checks for the evaluation of multiple dossiers for the same active substance Meeting document: WGII2014_APCP_5-2 For discussion Item 6 Technical equivalence assessments 6.1 Prallethrin (eca EL) Meeting document: WGII2014_APCP_6-1 4
6.2 Basic copper carbonate (eca FR) Meeting document: WGII2014_APCP_6-2 6.3 Copper hydroxide (eca FR) Meeting document: WGII2014_APCP_6-3 6.4 Copper (II) oxide (eca FR) Meeting document: WGII2014_APCP_6-4 Item 7 SID data requirements for in situ generated substances 7.1 In situ substances - summary 7.2 Peroxyoctanoic acid (POOA) (eca FR) Meeting document: WGII2014_APCP_7-2 Previous discussion(s): e-consultation of 24 October 2013 Item 8 Discussion of active substances 8.1 Carbon dioxide (eca NL) PT15 (new active substance) 8.2 Dinotefuran (eca UK) PT 18 (new active substance) 8.3 C(M)IT/MIT (eca FR) PT 2, 4, 6, 11, 12, 13 Meeting document: WGII2014_APCP_8-3 5
Item 9 AOB 9.1 R4BP 3 SECR to inform on versions 3.1 and 3.2 9.2 Lessons learned SECR to reflect on the experience gained 6
Efficacy Working Group Chair: Ann Thuvander Item 1 Welcome and apologies Item 2 Agreement of the agenda Item 3 Declarations of potential conflicts of interest in relation to the agenda Item 4 Administrative issues 4.1 Housekeeping issues Item 5 Discussion of active substances (in case of open issues) 5.1 CO 2 (eca NL) PT15 (new active substance) Meeting document: WGII2014_EFF_5-1 5.2 Dinotefuran (eca UK) PT 18 (new active substance) Meeting document: WGII2014_EFF_5-2 5.3 C(M)IT/MIT (eca FR) PT 2, 4, 6, 11, 12, 13 Meeting document: WGII2014_EFF_5-3 7
Item 6 Technical and guidance related issues 6.1 Work plan for Efficacy guidance Meeting document: WGII2014_EFF_6-1 6.2 Efficacy of piperonyl butoxide (PBO) for PT18 Meeting document: WGII2014_EFF_6-2 6.3 Possible update of Pt 14 guidance Document to be provided by SECR For discussion Item 7 AOB Efficacy guidance Workshop Item 1 Welcome and apologies Item 2 Discussion on Efficacy guidance under preparation Document to be provided by Drafting Group For discussion 8
Environment Working Group Chair: Heike Schimmelpfennig Item 1 Welcome and apologies Item 2 Agreement of the agenda Item 3 Declarations of potential conflicts of interest in relation to the agenda Item 4 Agreement of the draft minutes from WG-I-2014 Meeting document: WGII2014_ENV_4 Item 5 Administrative issues 5.1 Housekeeping issues Item 6 Discussion of active substances 6.1 CO 2 (eca NL) PT15 (new active substance) Meeting document: WGII2014_ENV_6-1 6.2 Dinotefuran (eca UK) PT 18 (new active substance) Meeting document: WGII2014_ENV_6-2 9
6.3 Copper pyrithione (eca SE) PT 21 Meeting document: WGII2014_ENV_6-3 Previous discussion(s): TM III 2011, TM I 2012 and TM II 2012; CA meeting in September 2013 6.4 C(M)IT/MIT (eca FR) PT 2, 4, 6, 11, 12, 13 Meeting document: WGII2014_ENV_6-4 Item 7 Technical and guidance related issues 7.1 Cut off criteria for groundwater assessment of biocides (UK) Meeting document: To be provided by UK Previous discussion: TM III 2013 7.2 Proposals for standard scenarios and parameter setting of the FOCUS groundwater scenarios when used in biocide exposure assessments (DE) Meeting document: To be provided by DE Previous discussion: e-consultation in 2012 7.3 Leaching to groundwater from paint, coatings and plaster (NL) Meeting document: To be provided by NL Previous discussion: TM II 2013 7.4 Volume IV Part B: Guidance on Environmental Risk Assessment Active Substance (ECHA) Meeting document: WGII2014_ENV_7-4 Previous discussion: TM II 2013 and TM IV 2013 7.5 Scenario for the biocidal use and emissions from oil platforms PT11/ PT12 for PEC calculation (NL) Meeting document: To be provided by NL Previous discussion: TM IV 2013 (presentation of intention) 7.6 Update on guidance development (ECHA) SECR to inform 10
Item 8 AOB 8.1 R4BP 3 SECR to inform on versions 3.1 and 3.2 8.2 Lessons learned from WG-I-2014 SECR to reflect on the experience gained o0o 11